[{"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "70 vials", "code_info": "Lot #: a) 20130321-E, Exp 6/21/2013; b) 20130215-F, Exp 5/15/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Modified Myers Cocktail Injection, all strengths and all presentations including a) Mod Meyer's Cocktail 37 mL and b) Modified Myers Cocktail 37 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-396-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "1 vial (10 mL)", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "BiMix Customs Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-294-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-467-2013", "product_description": "Vancomycin Opth Soln 25mg/ml PF, 10ml  Opthalmic Soln, 10 day expiration,", "product_quantity": "2", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-517-2013", "product_description": "Dallergy TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Laser Pharmaceuticals, LLC, Greenville, SC 29615, NDC 16477-160-01", "product_quantity": "31,739 bottles 100-count; 842,617 Bulk tablet bottles", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11L006 Exp. 10/13; Lot# 11L006  Exp. 10/13; Lot# 12B003 Exp 01/14; Lot# 12B003 Exp. 01/14; Lot#12D005  Exp. 03/14; Lot# 12D005 Exp. 03/14;  Lot# 12H001  Exp. 07/14."}, {"country": "United States", "city": "Parsippany", "address_1": "399 Interpace Parkway", "reason_for_recall": "Subpotent Drug: Product did not conform  to the 18-month stability test specification for active Free Benzocaine.", "address_2": "", "product_quantity": "27,718 cases 16 count and 7,551 cases 576 count", "code_info": "16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14,  AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398  Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,", "center_classification_date": "20130501", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC,  Dist. by: Reckitt Benckiser, Parsippany, NJ  07054", "report_date": "20130508", "classification": "Class III", "openfda": {}, "recalling_firm": "Reckitt Benckiser Inc", "recall_number": "D-310-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64652", "termination_date": "20140814", "more_code_info": "", "recall_initiation_date": "20130318", "postal_code": "07054", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-505-2013", "product_description": "AMBI 25DPH/7.5PEH, Antihistamine,  Nasal Decongestant,  Fruit Candy Flavor, 16 fl oz. bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0226-16", "product_quantity": "352 - 16 ounce bottles", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot # 12DQ005, Exp. 03/14."}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-490-2013", "product_description": "Gentamicin 24mg/60ml Irrigation, 15x60ml Syr   Irrigation, 14 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-425-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles (NDC 60793-854-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "195,201 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64341, Exp 04/13;  64928, Exp. 5/13; 65064, Exp. 5/13; 65233, Exp. 7/13; 66162, Exp. 8/13; 66365, Exp. 10/13; and 66677, Exp. 11/13; b) 64342, Exp. 4/13; 64929, Exp. 5/13; 65065, Exp. 5/13; 65234, Exp. 7/13; 65539, Exp. 7/13; 65901, Exp. 8/13; and 66163, Exp. 8/13"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA071583"], "brand_name": ["DIAZEPAM"], "generic_name": ["DIAZEPAM"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-3213"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["DIAZEPAM"], "rxcui": ["309845"], "spl_id": ["2d6df2eb-55ce-4d78-b268-99cbb512a687"], "spl_set_id": ["7e7dd743-a87b-4ab3-b6ae-f116cd0c8b0f"], "package_ndc": ["0409-3213-11", "0409-3213-12"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["Q3JTX2Q7TU"]}, "product_type": "Drugs", "event_id": "65315", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-501-2013", "product_description": "Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12", "product_quantity": "95,700 vials", "reason_for_recall": "Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.", "recall_initiation_date": "20130516", "center_classification_date": "20130531", "termination_date": "20141110", "report_date": "20130612", "code_info": "17-099-EV  Exp 05/14"}, {"country": "United States", "city": "Canton", "address_1": "1002 E 5th St", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Brower  Enterprises Inc., is recalling its WOW Health Enterprises Dietary Supplement, because it contains undeclared drug ingredients making it an unapproved drug.  FDA sample analysis has found the product to contain methocarbamol, dexamethasone, and diclofenac.", "address_2": "", "product_quantity": "17,555 Bottles", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "Nationwide and Puerto Rico (through the internet).", "state": "SD", "product_description": "WOW, Health Enterprises, Dietary Supplement, 30 Caplets,   Distributed by:  Health Enterprises, 1002 E 5th St., Canton, SD  57013.  Manufactured by Riger Natural, S. A. Mexico.", "report_date": "20130501", "classification": "Class I", "openfda": {}, "recalling_firm": "Brower Enterprises Inc", "recall_number": "D-267-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63867", "termination_date": "20131114", "more_code_info": "", "recall_initiation_date": "20121210", "postal_code": "57013-1925", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "244 vials", "code_info": "Lot #: a) Folic Acid 10 mg/30 mL: 20130204-D, Exp 5/4/2013; b) Folic Acid PF 10mg/mL 2 mL: 20130219-E, Exp 5/15/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Folic Acid Injection, all strengths and all presentations including a) Folic Acid 10 mg/mL 30 mL; b) Folic Acid PF 10 mg/mL 2 mL and 5 mL; c) Folic Acid 20 mg/mL 30 mL; d) Folic Acid 5 mg/mL 5 mL, 10 ml and 30 mL Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-366-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "4 vials (5 mL each)", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "17 Alpha Hydroxyprogesterone Caproate Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-286-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "48 vials", "code_info": "Lot #: 20130226-F, Exp 5/26/2013; 20130117-K, Exp 4/17/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Estradiol Cypionate Injection, all strengths and all presentations including a) Estradiol Cypionate 5 mg/mL 10 mL and b) Estradiol Cypionate 10 mg/mL 10 ml, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-364-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64372", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico, and Panama.  Military distribution made.", "recall_number": "D-577-2013", "product_description": "Voltaren Gel (diclofenac sodium topical gel) 1%, for topical use only, RX only, a) Packaged in 20 gm tubes, NDC 63481-684-83 (physician sample product) and b) 100 gm tubes, NDC 63481-684-47 (the 100 g tubes are also packaged 3/100-g tubes/packs (UPC code: 363481684030 NDC code: 6348168403) and 5/100-g tubes/packs (UPC code: 363481684054 NDC code: 6348168405),  Marketed by Endo Pharmaceuticals Inc., Chadds Ford, PA and Manufactured by Novartis Consumer Health, Inc, Parsippany, NJ.", "product_quantity": "a) 1,043,926 (20-gm) tubes and b) 3,385,481 (100-gm) tubes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.", "recall_initiation_date": "20130219", "center_classification_date": "20130606", "termination_date": "20141126", "report_date": "20130612", "code_info": "Lot #'s and Expiration dates:  a) 20 gm tubes:  10116298 05/31/14  10116299 05/31/14  10116300 05/31/14  10117402 07/31/14  10117403 07/31/14  10117404 08/31/14  10117405 08/31/14  10117406 08/31/14  10117407 10/31/14  10117408 10/31/14    b) 100 gm tubes:    10119436 10119436  10119437 10119437  10119438 10119438  10119439 10119439  10119440 10119440  10119441 10119441  10119442 10119442  10119443 10119443  10119444 10119444  10119445 10119445  10119446 10119446      100 gm/3 pack:    10085217 2/28/2013  10085218 2/28/2013  10085219 2/28/2013  10085220 2/28/2013  10085221 2/28/2013  10085222 2/28/2013  10085223 2/28/2013  10085224 2/28/2013  10085225 2/28/2013  10085226 2/28/2013  10085227 2/28/2013  10085228 2/28/2013  10085229 2/28/2013  10085230 2/28/2013  10085231 2/28/2013  10085232 2/28/2013  10085233 2/28/2013  10085234 2/28/2013  10085235 2/28/2013  10085236 2/28/2013  10085238 2/28/2013  10085239 2/28/2013  10085240 2/28/2013  10085241 2/28/2013  10085242 2/28/2013  10085243 2/28/2013  10085244 2/28/2013  10085245 2/28/2013  10085246 3/31/2013  10085247 3/31/2013  10085248 3/31/2013  10085249 3/31/2013  10085260 3/31/2013  10085261 3/31/2013  10085262 3/31/2013  10085263 3/31/2013  10085264 3/31/2013  10085265 3/31/2013  10085266 3/31/2013  10085267 3/31/2013  10085268 3/31/2013  10085269 3/31/2013  10085270 3/31/2013  10085271 3/31/2013  10085272 3/31/2013  10087039 3/31/2013  10087040 3/31/2013  10087041 3/31/2013  10087042 3/31/2013  10087043 3/31/2013  10087052 3/31/2013  10087053 3/31/2013  10087054 3/31/2013  10087055 3/31/2013  10087063 3/31/2013  10087064 3/31/2013  10087065 3/31/2013  10088276 4/30/2013  10088277 4/30/2013  10088278 4/30/2013  10088279 4/30/2013  10088280 4/30/2013  10088281 4/30/2013  10088282 4/30/2013  10088289 4/30/2013  10088290 4/30/2013  10088291 4/30/2013  10088292 4/30/2013  10088293 4/30/2013  10088294 4/30/2013  10088295 4/30/2013  10088296 4/30/2013  10088297 4/30/2013  10088298 4/30/2013  10088299 4/30/2013  10088300 4/30/2013  10088301 4/30/2013  10088302 4/30/2013  10088303 4/30/2013  10088304 4/30/2013  10088305 4/30/2013  10088306 4/30/2013  10088307 4/30/2013  10088308 4/30/2013  10088309 4/30/2013  10088310 4/30/2013  10088311 4/30/2013  10088312 4/30/2013  10088313 4/30/2013  10088314 4/30/2013  10088315 4/30/2013  10088897 5/31/2013  10088898 5/31/2013  10088899 5/31/2013  10088900 5/31/2013  10088901 5/31/2013  10088902 5/31/2013  10088903 5/31/2013  10088904 5/31/2013  10088905 5/31/2013  10088906 5/31/2013  10088907 5/31/2013  10088908 5/31/2013  10088909 5/31/2013  10088910 5/31/2013  10088911 6/30/2013  10088921 7/31/2013  10088922 7/31/2013  10088923 7/31/2013  10088924 7/31/2013  10088925 7/31/2013  10088926 7/31/2013  10088927 7/31/2013  10088928 7/31/2013  10088929 7/31/2013  10088930 7/31/2013  10088931 7/31/2013  10090306 4/30/2013  10090307 4/30/2013  10090308 4/30/2013  10092277 7/31/2013  10092278 7/31/2013  10092279 7/31/2013  10092280 7/31/2013  10092281 7/31/2013  10092282 7/31/2013  10092283 7/31/2013  10092284 8/31/2013  10092285 8/31/2013  10092288 8/31/2013  10092289 8/31/2013  10092290 8/31/2013  10092291 8/31/2013  10092292 8/31/2013  10092293 8/31/2013  10092294 8/31/2013  10094387 8/31/2013  10094388 8/31/2013  10094389 8/31/2013  10094390 8/31/2013  10094394 9/30/2013  10094395 9/30/2013  10094396 9/30/2013  10094397 9/30/2013  10094398 9/30/2013  10097030 9/30/2013  10097031 9/30/2013  10097032 9/30/2013  10097033 9/30/2013  10097035 10/31/2013  10097036 10/31/2013  10098681 10/31/2013  10098692 10/31/2013  10098693 10/31/2013  10098694 10/31/2013  10098695 10/31/2013  10098697 10/31/2013  10098698 10/31/2013  10098699 10/31/2013  10098700 10/31/2013  10098701 10/31/2013  10098702 10/31/2013  10098703 10/31/2013  10098704 10/31/2013  10098708 11/30/2013  10098709 11/30/2013  10100515 11/30/2013  10100516 11/30/2013  10100517 11/30/2013  10100524 12/31/2013  10100525 12/31/2013  10100526 12/31/2013  10100527 12/31/2013  10100528 12/31/2013  10102312 12/31/2013  10102313 12/31/2013  10102314 12/31/2013  10102315 12/31/2013  10102316 12/31/2013  10102317 12/31/2013  10102318 12/31/2013  10102319 1/31/2014  10102320 1/31/2014  10102321 1/31/2014  10102322 1/31/2014  10102323 1/31/2014  10102324 1/31/2014  10102325 1/31/2014  10102326 1/31/2014  10102328 1/31/2014  10102329 1/31/2014  10102330 1/31/2014  10102331 1/31/2014  10102332 1/31/2014  10102337 1/31/2014  10102338 1/31/2014  10104246 2/28/2014  10104247 2/28/2014  10104248 2/28/2014  10104249 2/28/2014  10104250 2/28/2014  10104251 2/28/2014  10104252 2/28/2014  10104257 2/28/2014  10104258 2/28/2014  10104259 2/28/2014  10104260 2/28/2014  10104261 2/28/2014  10104262 2/28/2014  10107735 2/28/2014  10107736 3/31/2014  10107737 3/31/2014  10107738 3/31/2014  10107739 3/31/2014  10107740 3/31/2014  10107741 3/31/2014  10107749 3/31/2014  10107750 3/31/2014  10107751 3/31/2014  10107752 3/31/2014  10107753 3/31/2014  10107754 3/31/2014  10110430 4/30/2014  10110431 4/30/2014  10110432 4/30/2014  10110433 4/30/2014  10110434 4/30/2014  10110435 4/30/2014  10110436 4/30/2014  10110437 4/30/2014  10110438 4/30/2014  10110439 4/30/2014  10110440 4/30/2014  10110441 4/30/2014  10110442 4/30/2014  10110443 4/30/2014  10110444 4/30/2014  10111080 4/30/2014  10111081 4/30/2014  10111082 5/31/2014  10111083 5/31/2014  10113475 5/31/2014  10113476 5/31/2014  10113477 5/31/2014  10113478 5/31/2014  10113479 5/31/2014  10113480 5/31/2014  10113481 5/31/2014  10113482 5/31/2014  10113483 5/31/2014  10113484 5/31/2014  10113485 6/30/2014  10113486 6/30/2014  10113487 6/30/2014  10113488 6/30/2014  10113489 6/30/2014  10113490 6/30/2014  10115859 6/30/2014  10115860 6/30/2014  10115861 6/30/2014  10115862 6/30/2014  10115863 6/30/2014  10115864 6/30/2014  10115865 6/30/2014  10115866 6/30/2014  10115867 6/30/2014  10115868 6/30/2014  10115869 6/30/2014  10115870 6/30/2014  10115871 7/31/2014  10115872 7/31/2014  10115873 7/31/2014  10115876 7/31/2014  10115877 7/31/2014  10115878 7/31/2014  10117411 7/31/2014  10117413 7/31/2014  10117414 7/31/2014  10117416 7/31/2014  10117417 7/31/2014  10119416 9/30/2014  10119417 9/30/2014  10119418 9/30/2014  10119419 9/30/2014  10119420 9/30/2014  10119429 9/30/2014  10119430 9/30/2014  10119431 9/30/2014  10119432 9/30/2014  10119433 10/31/2014  10119434 10/31/2014  10120546 8/31/2014  10120547 8/31/2014  10120548 8/31/2014  10120549 8/31/2014  10120550 8/31/2014  10120551 8/31/2014  10120552 8/31/2014  10120553 8/31/2014  10120554 8/31/2014  10120555 9/30/2014  10120556 9/30/2014  10120557 9/30/2014  10120558 9/30/2014    100 gm/5 pack:    10085250 3/31/2013  10085251 3/31/2013  10085252 3/31/2013  10085253 3/31/2013  10085254 3/31/2013  10085255 3/31/2013  10085256 3/31/2013  10085257 3/31/2013  10085258 3/31/2013  10085259 3/31/2013  10087044 3/31/2013  10087048 3/31/2013  10087049 3/31/2013  10087050 3/31/2013  10087051 3/31/2013  10087056 3/31/2013  10087057 3/31/2013  10087058 3/31/2013  10087059 3/31/2013  10087060 3/31/2013  10087061 3/31/2013  10087062 3/31/2013  10088283 4/30/2013  10088284 4/30/2013  10088285 4/30/2013  10088286 4/30/2013  10088287 4/30/2013  10088288 4/30/2013  10088912 6/30/2013  10088913 6/30/2013  10088914 6/30/2013  10088915 6/30/2013  10088916 6/30/2013  10088917 6/30/2013  10088918 6/30/2013  10088919 6/30/2013  10088920 7/31/2013  10092286 8/31/2013  10092287 8/31/2013  10094391 8/31/2013  10094392 8/31/2013  10094393 9/30/2013  10097029 9/30/2013  10097034 9/30/2013  10098696 10/31/2013  10098705 10/31/2013  10098706 10/31/2013  10098707 11/30/2013  10100518 11/30/2013  10100519 11/30/2013  10100520 11/30/2013  10100521 11/30/2013  10100522 12/31/2013  10100523 12/31/2013  10102327 1/31/2014  10102333 1/31/2014  10102334 1/31/2014  10102335 1/31/2014  10102336 1/31/2014  10104253 2/28/2014  10104254 2/28/2014  10104255 2/28/2014  10104256 2/28/2014  10107742 3/31/2014  10107743 3/31/2014  10107744 3/31/2014  10107745 3/31/2014  10107746 3/31/2014  10107747 3/31/2014  10107748 3/31/2014  10111084 5/31/2014  10111085 5/31/2014  10111086 5/31/2014  10111087 5/31/2014  10111088 5/31/2014  10111089 5/31/2014  10111090 5/31/2014  10115874 7/31/2014  10115875 7/31/2014  10117412 7/31/2014  10117415 7/31/2014  10119409 7/31/2014  10119410 7/31/2014  10119411 7/31/2014  10119412 8/31/2014  10119413 8/31/2014  10119414 8/31/2014  10119415 8/31/2014  10119435 10/31/2014  10119436 10/31/2014"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-455-2013", "product_description": "Bimix Inj 30:1 MDV: 5ml, 10 ml, 3x10ml, 2x10ml  Penile Injection, 30 and 90 day expiration,", "product_quantity": "128", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Bartow", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "64409", "recalling_firm": "OLAAX International", "address_1": "6105 Riverlake Blvd", "address_2": "N/A", "postal_code": "33830-7754", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide, Puerto Rico and  Venezuela and Bolivia", "recall_number": "D-600-2013", "product_description": "MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL", "product_quantity": "600 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.", "recall_initiation_date": "20130212", "center_classification_date": "20130613", "termination_date": "20191001", "report_date": "20130619", "code_info": "All Lots"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-537-2013", "product_description": "TL-DEX DM,  Cough Suppressant  Decongestant, Expectorant 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-067-16", "product_quantity": "2532 - 16 ounce bottles.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11AQ003  Exp 12/12."}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-513-2013", "product_description": "AMBI 40PSE/400GFN, 100 tablet bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0408-01", "product_quantity": "886 bottles  - 100-count tablets", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot # 12C007 Exp. 02/14; Lot # 12C008 Exp. 02/14."}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-441-2013", "product_description": "Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "3,844,402 tablets", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: HD31411, Exp May-13; HC04112, Exp Aug-13."}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-256-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles ( NDC 60793-855-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "9213 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a) 67343B, Exp. 01/14; b) 66902B, Exp. 12/13"}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-569-2013", "product_description": "Carnosine 5% Opth drop, 40 mL vial, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "1 vial of 40ml", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "286 vials (30 mL vials each)", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Sodium Tetradecyl Sulfate Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-272-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA065056"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2263", "0093-2264", "0093-4160", "0093-4155", "0093-4161", "0093-2267", "0093-2268", "0093-3107", "0093-3109"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308177", "308182", "308189", "308191", "308192", "308194", "313850", "598025"], "spl_id": ["31223839-1653-4906-826a-f9d6af179334"], "spl_set_id": ["4c0f348a-a65d-409c-8668-207c82a5e3cb"], "package_ndc": ["0093-2263-01", "0093-2264-01", "0093-4160-76", "0093-4160-78", "0093-4160-73", "0093-4155-79", "0093-4155-73", "0093-4155-80", "0093-4161-76", "0093-4161-78", "0093-4161-73", "0093-2267-01", "0093-2268-01", "0093-3107-01", "0093-3107-05", "0093-3109-53", "0093-3109-05"], "is_original_packager": [true], "upc": ["0300933107051", "0300932264014", "0300934161731", "0300933109055", "0300932267015", "0300932268012", "0300932263017", "0300934160734", "0300934155730"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "65050", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-598-2013", "product_description": "Amoxicillin for Oral Suspension, USP 400mg/5mL, NDC 0093-4161-78 (75ml) and 0093-4161-73 (100mL)", "product_quantity": "758,554 bottles", "reason_for_recall": "Discoloration: This recall is being carried out due to a yellow to brown discolored Amoxicillin powder on the inner foil seal of the bottles.", "recall_initiation_date": "20130426", "center_classification_date": "20130611", "termination_date": "20131224", "report_date": "20130619", "code_info": "a) NDC 0093-4161-78 -- lot numbers 35426081A, 35426082A, 35426083A, 35426084A, Exp: 06/2014; 35426648A, Exp 08/2014; 35427222A, 35427224A, 35427226A, 35427223A, 35427227A, 35427228A, Exp 10/2014; and   b) NDC 0093-4161-73 -- lot numbers 35426631A, 35426632A, 35426633A, 35426634A, 35426635A, 35426636A, 35426637A, 35426638A, 35426639A, 35426640A, 35426680B, 35426681B, 35426682B, Exp 08/2014; 35426641A, 35426642A, Exp 09/2014."}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-548-2013", "product_description": "Methotrexate 25mg/mL Injectable, 10 mL vials, Compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "19 vials of 10ml", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "63 vials", "code_info": "Lot #: a) Hydrochloric Acid 0.6%: 20130212-H, Exp 5/12/2013; b) Hydrochloric Acid 2%: 2013012952000AE, Exp 4/29/2013  .", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Hydrochloric Acid Injection, all strengths and all presentations including a) Hydrochloric Acid 0.6%, b) Hydrochloric Acid 2%, c) Hydrochloric Acid Injection 0.06% 30 mL, d) Hydrochloric Acid 2 mg/mL Injection 30 mL vial, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-372-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075866"], "brand_name": ["PORTIA"], "generic_name": ["LEVONORGESTREL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9020"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238019", "748797", "748878", "751890"], "spl_id": ["4d63fa4a-ff46-4f2e-b9d5-cab4f5fe1d85"], "spl_set_id": ["c78b236b-85c4-4258-a524-cea08775100c"], "package_ndc": ["0555-9020-79", "0555-9020-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "64607", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-245-2013", "product_description": "Portia (levonorgestrel and ethinyl estradiol) Tablets, USP, 0.15 mg/0.03 mg, 28-count tablets (containing 21 pink tablets followed by 7 white tablets) per blister card packaged in 6 blister cards per carton, Rx only, Barr Laboratories, Inc., Pomona, NY  10970, NDC 0555-9020-58.", "product_quantity": "17,661 blister cards", "reason_for_recall": "Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.", "recall_initiation_date": "20130312", "center_classification_date": "20130410", "termination_date": "20140115", "report_date": "20130417", "code_info": "Lot #: 33801951A, and 33802189A, Exp 03/13", "more_code_info": ""}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and  one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.", "address_2": "Suite 180", "product_quantity": "1395 Vials total; 900x1 ml vials 20121105-B; 90x 2ml vials of lot 20121112-G and 495x1 ml vials of lot 20121112-G.", "code_info": "Lot #s: 20121105-B, 20121112-G", "center_classification_date": "20130515", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Methylprednisolone Preservative Free 40 mg/ml Injectible Suspension, 1 mL Vials and 2 mL Vials and 1 mL pre-filled syringes, For Office Use Only, Manufactured by Green Valley Drugs, Henderson, NV.", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "Green Valley Drugs", "recall_number": "D-321-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63953", "termination_date": "20130517", "more_code_info": "", "recall_initiation_date": "20121204", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "70 vials", "code_info": "Lot #: a) Thiamine 100 mg/30 mL: 20130130-G, Exp 4/30/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Thiamine Hydrochloride Injection, all strengths and all presentations including a) Thiamine 100 mg/30 mL, b) Thiamine Hydrochloride 100 mg/mL with preservative 30 mL, c) Thiamine Hydrochloride 50 mg/mL with preservative 30 mL, d) Thiamine Hydrochloride 100 mg/mL preservative free 10 mL and 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-414-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65115", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-452-2013", "product_description": "Budesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit dose (3 x 10 capsules blister packaged) per box, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV  26505; Packaged and Distributed by: UDL Laboratories, Inc., Rockford, IL  61103, NDC 51079-020-03.", "product_quantity": "1,621 boxes", "reason_for_recall": "Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification (OOS) result for dissolution testing.", "recall_initiation_date": "20130515", "center_classification_date": "20130522", "termination_date": "20150507", "report_date": "20130529", "code_info": "Lot No: 3037382, Exp 09/13"}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-258-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles ( NDC 60793-857-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "7901 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a)  67013B, Exp. 01/14; b) 66900B, Exp. 01/14"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-495-2013", "product_description": "Pyridoxine 100mg/ml Inj MDV, 1X30 ml  30 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"country": "United States", "city": "Commerce", "address_1": "5560 E 61st St", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs", "address_2": "", "product_quantity": "686,000 capsules", "code_info": "1 count blister: Lot# 01MNU0912, Exp: 09/15; Lot# 01X0412-1, Exp: 04/15; Lot# 021647, Exp: 12/13,     5 count blister: Lot# 05X0412, Exp: 04/16,     10 count blister: Lot# 10X0412, Exp: 04/16; Lot# 10M0111, Exp: 01/14.", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "libigrow XXXTREME Capsules, MAXIMUM STRENGTH FORMULA, 1000 mg, supplied in 1, 5 and 10 count blister packs, Distributed By Kretek International, Inc. Moorpark, CA 930210    1 count blister: UPC 705105830735,  5 count blister: UPC 610585435939,  10 count blister:  UPC 610585435922.", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "Performance Plus Marketing, Inc.", "recall_number": "D-333-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "63916", "termination_date": "20131114", "more_code_info": "", "recall_initiation_date": "20121217", "postal_code": "90040-3406", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-518-2013", "product_description": "Dallergy CHEWABLE TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Laser Pharmaceuticals, LLC, Greenville, SC 29615, NDC 16477-152-01", "product_quantity": "8296 bottles  - 100-count and 153,028 Bulk tablets", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 12B001 Exp. 01/14; Lot# 12B001 Exp. 01/14; Lot# 12B002 Exp 01/14; Lot# 12F013  Exp. 05/2014; Lot# 12F013 Exp. 05/2014."}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "98 vials", "code_info": "Lot #: a) Edetate Disodium_150/30 mL: 20130201-E, Exp 5/2/2013; b) Edetate Disodium_150/100 mL: 20130124-B, 4/24/2013; 20130213-B, Exp 5/13/2013; 20130213-C, Exp 5/13/2013; 20130401-B, Exp 7/1/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Edetate Disodium Injection, all strengths and all presentations including a) Edetate Disodium 150/30 mL and b) Edetate Disodium 150/100 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-361-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-494-2013", "product_description": "Meperidine 100mg/ml MDV, 5ml  90 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "54 vials", "code_info": "Lot #: 20130129-F, Exp 4/29/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Phenylephrine Injection, all strengths and all presentations including Phenylephrine 1% 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-398-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-493-2013", "product_description": "Lidocaine 2% Inj MDV, 20 ml   30 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-443-2013", "product_description": "Lloyd Thyro-Tab 0.175 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "5,768,782 tablets", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: HC29411, Exp May-13; HD00512, Exp Jul-13; HA08912, Exp Oct-13."}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-195", "68462-196", "68462-197", "68462-198"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["a6e006b3-4256-4cbb-8ad1-b71f363430cd"], "spl_set_id": ["6ca01de3-a0f9-4cfb-b36a-723c7c42e2a4"], "package_ndc": ["68462-195-90", "68462-195-05", "68462-196-90", "68462-196-05", "68462-197-90", "68462-197-05", "68462-198-90", "68462-198-05"], "is_original_packager": [true], "upc": ["0368462195901", "0368462198902"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "64995", "recalling_firm": "Glenmark Generics Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-330-2013", "product_description": "Glenmark Pravastatin Sodium Tablets ,40 mg, 90-count bottle (NDC 68462-197-90), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India  Manufactured for :Glenmark Generics USA Mahwah, NJ 07430", "product_quantity": "246,528 bottles", "reason_for_recall": "Chemical Contamination: Pravastatin Sodium Tablets isbeing recalled due to complaints related to an off-odor described as moldy, musty or fishy in nature.", "recall_initiation_date": "20130405", "center_classification_date": "20130516", "termination_date": "20141009", "report_date": "20130522", "code_info": "Lot # 02121059  Exp 03/15  Lot # 02121484  Exp 04/15  Lot # 02121530  Exp 04/15  Lot#  02121665  Exp     05/15  Lot#  02121669  Exp     05/15  Lot#  02121689  Exp     05/15  Lot#  02121705  Exp 05/15  Lot#  02123434  Exp 10/15  Lot#  02123446  Exp 10/15  Lot#  02123633  Exp 11/15  Lot#  02123677  Exp 11/15  Lot#  02123685  Exp 11/15  Lot#  02123695  Exp 11/15  Lot#  02123823  Exp 11/15  Lot#  02123833  Exp 11/15  Lot#  02123836  Exp 11/15  Lot#  02123853  Exp 11/15  Lot#  02123859  Exp 11/15  Lot#  02130021  Exp 12/15  Lot#  02130059  Exp 12/15  Lot#  02130079  Exp 12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-528-2013", "product_description": "Lusair Liquid, 1 PINT bottle, OTC, Marketed by:  Pernix Therapeutics, Gonzales, LA 70737 NDC 23359-017-16", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11AQ004 Exp. 12/12; Lot# 11AQ005  Exp. 12/12; Lot # 11AQ006  Exp. 12/12; Lot# 11AQ007 Exp. 12/12; Lot # 11BQ012 - 19728 20 mL, Exp. 01/13; Lot# 11LQ003  Exp. 10/13; Lot# 11LQ004 Exp. 10/13; Lot# 11LQ005 Exp 10/13; Lot# 11LQ006 Exp. 10/13."}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "BiMix Standard Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-283-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boothwyn", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65180", "recalling_firm": "Pentec Health", "address_1": "4 Creek Pkwy Ste A", "address_2": "N/A", "postal_code": "19061-3132", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dialysis Centers  Direct to patient", "recall_number": "D-588-2013", "product_description": "Proplete 60 - 69 KG (Intradialytic Parenteral Nutrition - dialysate solution with added amino acids), in 555mL bag, Pentec Health Inc, 4 Creek Parkway Suite A  Boothwyn, PA  19061-3132", "product_quantity": "59 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.", "recall_initiation_date": "20130515", "center_classification_date": "20130606", "termination_date": "20141216", "report_date": "20130612", "code_info": "Compounding Date: 04/23/13, 04/24/13, 04/29/13, 05/01/13    Discard after: 05/20/13, 05/22/13"}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-260-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60793-859-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "10121 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a) 67507B, Exp. 02/14; b) 67508B, Exp. 02/14"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "273 vials", "code_info": "Lot #: 20130212-A, Exp 5/12/2013; 20130122-E, Exp 4/22/2013; 20130212-D, Exp 5/12/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Dexpanthenol Injection, all strengths and all presentations including Dexpanthenol 250 mg/30 mL; Dexpanthenol 250 mg/mL 10 mL, 30 mL, 50 mL; and Dexpanthenol 250 mg/mL 10 mL P.F.; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-358-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "El Paso", "address_1": "1550 Northwestern Drive", "reason_for_recall": "Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.", "address_2": "", "product_quantity": "544,500 kits", "code_info": "All lots with expiry between 07/11 to 08/14.", "center_classification_date": "20130328", "distribution_pattern": "Nationwide, Puerto Rico, Virgin Islands, Malaysia, and United Kingdom", "state": "TX", "product_description": "FREPP/SEPP Kit containing 1 FREPP (povidone iodine 2% aqueous solution), Net 1.1 mL and 1 SEPP (povidone iodine 10% USP), Net 0.67 mL per kit, packaged in 20 kits per carton, Cat. No 260288, NDC 54365-202-99, CareFusion, Leawood, KS  66211.", "report_date": "20130403", "classification": "Class II", "openfda": {}, "recalling_firm": "CareFusion 213, LLC", "recall_number": "D-229-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64583", "termination_date": "20140512", "more_code_info": "", "recall_initiation_date": "20130304", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-536-2013", "product_description": "Mesehist WC,  Antihistamine, Antitussive, Decongestant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0075-16", "product_quantity": "4,884 - 16 ounce bottles", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11DQ001 Exp 03/13; Lot# 11MQ010 Exp. 11/13."}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "227 vials", "code_info": "Lot #: a) Edatate Calcium Disodium 300 mg/mL 100mL: 20130319-H, Exp 6/19/2013; 2010318-N, Exp 6/18/2013; b) Edetate Calcium Disodium 300-30 mL: 20130205-H, Exp 5/5/2013; 20130318-N, Exp 6/18/2013; 20130319-H, Exp 6/19/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Edetate Calcium Disodium Injection, all strengths and all presentations including a) Edetate Calcium Disodium 300 mg/mL 100 mL, b) Edetate Calcium Disodium 300-30 mL, c) Calcium Edetate 200 mg/mL 15 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-362-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-526-2013", "product_description": "BroveX PSB LIQUID, Antihistamine, Decongestant, a) 16 fl oz. bottle, OTC, NDC 58605-150-01  b) 20 ml NDC 58605-150-02,  Manufactured for: Pernix Therapeutics, Gonzales, LA 70737", "product_quantity": "57,936 bottles - 20 mL and 7,476  bottles -16 ounce", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11CQ005  Exp. 02/13; Lot# 11LQ002  Exp. 10/13; Lot # 12CQ005-Exp. 02/14; Lot# 12EQ003  Exp. 04/14; Lot# 12EQ004  Exp. 04/14; Lot# 12JQ004  Exp. 08/14."}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "10 vials (30 mL each)", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Comprehensive injection #4 - SS varied injectable Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-280-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-487-2013", "product_description": "Methylcobalamin Inj 25mg/ml Syr: 8x0.06mlsyr, 10x0.06 ml syr, 12x0.06 ml syr     Subcutaneous, 30 and 90 day expiration,", "product_quantity": "5", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-532-2013", "product_description": "TG 40PSE/400GFN Tablets, 1000 count bottle, OTC Manufactured by: TG United, Inc. Brooksville, FL 34604  NDC 29273-0706-10", "product_quantity": "386  - 1000-count bottles", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11A006 Exp 12/12; Lot# 11A007  Exp 12/12; Lot# 11G004  Exp 06/14; Lot# 11G005  Exp 06/14; Lot# 12C004  Exp 02/14; Lot# 12F007  Exp 05/14; Lot# 12F008 Exp.05/14; Lot #12F009  Exp. 05/14; Lot# 12G005  Exp 06/14."}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "11 vials (10 mL each)", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "Progesterone in Olive Oil Injectable  Balanced Solutions, Compounding Pharmacy a division ofAxium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-277-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-261-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles ( NDC 60793-860-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "14464 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a) 66671B, Exp. 11/13; 67512B, Exp. 02/14 b) 66739B Exp. 11/13; 67513B Exp. 02/14"}, {"country": "United States", "city": "Camarillo", "address_1": "5187 Camino Ruiz", "reason_for_recall": "Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer", "address_2": "", "product_quantity": "6158 bottles", "code_info": "Exp     NDC                        Lot #  Date     60429-046-10  69393A1  09/2015     60429-046-1 0  69395A1  09/2015     60429-046-10  69495A1  10/2015     60429-046-10  69496A1  10/2015     60429-046-01  69497A1  02/2014     60429-046-10  69524A1  10/2015     60429-046-10  69524A2  10/2015     60429-046-10  69525A1  10/2015     60429-046-10  69525A2  10/2015", "center_classification_date": "20130407", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP, 20 mg/25 mg, 100 (NDC 60429-046-01)  and 1,000 (NDC 60429-046-10) count bottles, Rx only, GSMS Inc., Camarillo, CA", "report_date": "20130417", "classification": "Class II", "openfda": {}, "recalling_firm": "Gsms", "recall_number": "D-244-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64695", "termination_date": "20130903", "more_code_info": "", "recall_initiation_date": "20130311", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-488-2013", "product_description": "Hydroxyprogesterone Inj 250mg/ml MDV, 5 ml  Intramuscular, 30 day expiration,", "product_quantity": "5", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64339", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "4 Gatehall Dr Fl 3rd", "address_2": "N/A", "postal_code": "07054-4518", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-240-2013", "product_description": "TEV-TROPIN (somatropin (rDNA origin) for injection) 5 mg (15 IU).  Prescription Only.  Distributed By:  TEVA Biologics & Specialty Products Division of Teva Pharmaceuticals USA, Sellersville, PA 18960  Manufactured in Israel.", "product_quantity": "126 injectors", "reason_for_recall": "Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A", "recall_initiation_date": "20130201", "center_classification_date": "20130402", "termination_date": "20130710", "report_date": "20130410", "code_info": "LOT #201131320087 Exp 09/15"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64372", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico, and Panama.  Military distribution made.", "recall_number": "D-574-2013", "product_description": "Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis, MN.", "product_quantity": "99,660  tubes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..", "recall_initiation_date": "20130219", "center_classification_date": "20130606", "termination_date": "20141126", "report_date": "20130612", "code_info": "Lot numbers and exp dates:  10108716  31-Mar-2013,   10111510  30-Apr-2013, 10113801  31-May-2013, 10113839  30-Apr-2013, 10115616  31-Aug-2013"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-450-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1326-01", "product_quantity": "32,345 Bottles", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #r: 1095922, Exp May-13; 1097735, Exp Jul-13; 1099892, Exp Oct-13."}, {"country": "United States", "city": "San Diego", "address_1": "6225 Progressive Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico.", "address_2": "# 200", "product_quantity": "11,580 cartons", "code_info": "Lot #: 11611B0, Batch # 114039, Exp 10/14", "center_classification_date": "20130425", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Pentrexcilina (acetaminophen, chlorpheniramine maleate, and phenylephrine HCl) tablets, 20-count tablets per carton, Distributed by: Laboratorios Norimex Co., San Diego, CA  92154, UPC 0 91965 02002 8.", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "OPMX, LLC", "recall_number": "D-299-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64933", "termination_date": "20130822", "more_code_info": "", "recall_initiation_date": "20130412", "postal_code": "92154-6643", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Tulsa", "address_1": "12515 E 55th St Ste 100", "reason_for_recall": "Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API.", "address_2": "", "product_quantity": "3660 capsules", "code_info": "5YLZ EXP 04/13, 5ZCE EXP 04/13, 61TX EXP 04/13, 65YD EXP 07/13, 6COJ EXP 09/13, 4ZT6 EXP 02/12, 58HD EXP 02/12, 5G4L EXP 08/12, 5KBU EXP 10/12, 5M3W EXP 10/12, 5OHI EXP 10/12, 6JHL EXP 01/14, 6HJQ EXP 01/14", "center_classification_date": "20130327", "distribution_pattern": "FL, NC, TX, CO, VA, SC, GA, KS, LA, MO", "state": "OK", "product_description": "PHYSICIANS TOTAL CARE, TETRACYCLINE, 500 mg, 30 CAPSULES, bottle MFG. BY: TEVA PHARMACEUTICALS USA, SELLERSVILLE PA 18960 NDC 54868-0025-09", "report_date": "20130403", "classification": "Class II", "openfda": {}, "recalling_firm": "Physicians Total Care, Inc.", "recall_number": "D-222-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "63891", "termination_date": "20130517", "more_code_info": "", "recall_initiation_date": "20120220", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-475-2013", "product_description": "Folic Acid Inj 5mg/ml MDV, 10 ml  Subcutaneous, 90 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-516-2013", "product_description": "NoHist TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Distributed by: Larken Laboratories, Inc., Canton, MS 39046, NDC 68047-173-01", "product_quantity": "4824 bottles - 100-count", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11K010 Exp. 09/13."}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-540-2013", "product_description": "Tri-Dex PE, Antihistamine, Antitussive, Nasal Decongestant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-088-16", "product_quantity": "12,198 - 16 ounce bottles.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11FQ004  Exp 05/13; Lot# 11KQ001 Exp. 09/13; Lot# 11KQ002  Exp. 09/13; Lot#11KQ003  Exp. 09/13; Lot# 12HQ010  Exp. 07/14."}, {"status": "Terminated", "city": "Sunrise", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64846", "recalling_firm": "Actavis South Atlantic LLC", "address_1": "13800 Nw 2nd St Ste 190", "address_2": "N/A", "postal_code": "33325-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-248-2013", "product_description": "buPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic LLC, Sunrise, FL  33325; Packaged by: American Health Packaging, Columbus, OH  43217; NDC 67767-142-30.", "product_quantity": "555,672 bottles", "reason_for_recall": "Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.", "recall_initiation_date": "20130322", "center_classification_date": "20130412", "termination_date": "20140509", "report_date": "20130424", "code_info": "Lot #: CC1D11A, CC1D12A, CC1D17A, CC1D18A, CD1D05A, CD1D07A, CD1D08A, CD1D14A, CD1D15A, CD1D16A, CE1D08A, Exp 03/13;     CE1D03A, CE1D04A, CE1D07A, CE1D06A, CE1D05A, CE1D13A, CE1D14A,  CE1D15A, Exp 04/13;     CF1D01A, CE1D24A, CF1D02A, Exp 05/13;     CH1D08A, CH1D09A, Exp 07/13;     CJ1D01A, CH1D11A, CH1D10A, CJ1D09A, CJ1D02A, CJ1D10A Exp 08/13;     CL1D05A, CL1D06A, CK1D05B, CK1D06A, Exp 10/13;     CL1D08A, CM1D01A, CM1D02A, Exp 11/13"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-538-2013", "product_description": "TL Hist DM, Antihistamine, Decongestant, Cough Suppressant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872,     NDC 13811-068-16", "product_quantity": "98,202 16 ounce bottles.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11CQ011  Exp 02/13; Lot# 11DQ007 Exp. 03/13; Lot# 11DQ008  Exp. 03/13; Lot# 11EQ002  Exp. 04/13; Lot # 11KQ004  Exp 09/13; Lot# 11KQ005  Exp. 09/13"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "319 vials", "code_info": "Lot #: 20130130-J, Exp 4/30/2013; 20130225-D, Exp 5/25/2013; 20130315-I, Exp 6/15/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Pyridoxine Hydrochloride Injection, all strengths and all presentations including Pyridoxine 100 mg/mL 30 mL, 50 mL, and 10 mL PF SDV, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-403-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.", "address_2": "", "product_quantity": "10,373 bottles", "code_info": "Lot #: C0671212A, Exp 12/14", "center_classification_date": "20130425", "distribution_pattern": "Nationwide", "state": "AL", "product_description": "GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL  35811,  NDC 0603-3745-21.", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualitest Pharmaceuticals", "recall_number": "D-298-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64960", "termination_date": "20140113", "more_code_info": "", "recall_initiation_date": "20130419", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-483-2013", "product_description": "Methylcobalamin Inj 1mg/ml MDV, 10 ml, 15 ml, 20 ml, 30 ml, 4x30 ml  Subcutaneous, 90 day expiration,", "product_quantity": "14", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"country": "United States", "city": "Fajardo", "address_1": "Road 195, Km 1.1", "reason_for_recall": "Chemical contamination: Firm's inspection discovered the  presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.", "address_2": "Union Street", "product_quantity": "17,136 bottles", "code_info": "Lot # 507694A; exp 02/13  Lot # 510041C; exp 05/13", "center_classification_date": "20130430", "distribution_pattern": "US Nationwide and Puerto Rico", "state": "PR", "product_description": "Jevantique (norethindrone acetate and ethinyl estradiol) tablets; 1.0 mg/5.0 mcg, 90 count bottle (NDC# 52544-237-19), Rx only, Manufactured by Warner Chilcott Company, LLC, Fajardo, PR 00738, Distributed by Watson Pharma, Inc. Corona, CA 92880.", "report_date": "20130508", "classification": "Class III", "openfda": {}, "recalling_firm": "Warner Chilcott Company LLC", "recall_number": "D-304-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64459", "termination_date": "20140609", "more_code_info": "", "recall_initiation_date": "20130215", "postal_code": "00738", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-571-2013", "product_description": "MIC (Methionine, Inositol, and Choline) Injectable, 30 mL vials, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "10 vials of 30 mL each", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-474-2013", "product_description": "PHMB Opth Soln 0.02%, 10 ml  Opthalmic Soln, 30 day expiration,", "product_quantity": "2", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-427-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "103,796 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64333, Exp. 5/13; 64937, Exp. 6/13; 65629, Exp. 7/13; and 66296, Exp. 9/13; b) 64931, Exp. 5/13 and 65766, Exp. 7/13"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-482-2013", "product_description": "Hydroxycobalamin Inj 2500 mcg/ml MDV, 2x30ml  Subcutaneous, 90 day expiration,", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "5255 vials and syringes", "code_info": "Lot #: a) HCG 1000u/mL: 20130319-E, Exp 5/19/2013; b) HCG 1000u/mL 10mL: 20130221-J, Exp 4/21/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Human Chorionic Gonadotropin Injection, all strengths and all presentations including a) HCG 1000u/mL, b) HCG 1000u/mL 10mL, c) HCG 1000u Folic 400 mcg Methyl 5 mg 10 mL, d) HCG Kit 1 Day w/ Drug; HCT 750u/0.75 mL Pre-Filled Syringe, e) HCG Syringe 150iu/0.15 mL, f) HCG 1500u/1.5 mL Pre-Filled Syringe, g) HCG 5000 unit/5 mL vial, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-370-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "140 vials", "code_info": "Lot #: 20130225-H, Exp 5/25/2013; 20130130-I, Exp 4/30/2013; 20130311-I, Exp 6/11/2013.", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Hydrogen Peroxide Injection, all strengths and all presentations including Hydrogen Peroxide 3% 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-373-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boothwyn", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65180", "recalling_firm": "Pentec Health", "address_1": "4 Creek Pkwy Ste A", "address_2": "N/A", "postal_code": "19061-3132", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dialysis Centers  Direct to patient", "recall_number": "D-586-2013", "product_description": "Proplete 40 - 44 KG (Intradialytic Parenteral Nutrition - dialysate solution with added amino acids), in a) 385mL and b) 390mL, Pentec Health Inc  4 Creek Parkway Suite A Boothwyn, PA  19061-3132", "product_quantity": "9 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.", "recall_initiation_date": "20130515", "center_classification_date": "20130606", "termination_date": "20141216", "report_date": "20130612", "code_info": "Compounding Date: 04/24/13 Discard after: 05/15/13"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "64197", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-262-2013", "product_description": "Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA; NDC 0409-7929-09.", "product_quantity": "143,136 flexible containers", "reason_for_recall": "Non-Sterility: Confirmed customer complaint of product contaminated with mold.", "recall_initiation_date": "20130125", "center_classification_date": "20130417", "termination_date": "20150821", "report_date": "20130424", "code_info": "Lot #: 05-019-JT*, Exp 05/01/13; lot number * may be followed by 01, 90, or 91."}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-444-2013", "product_description": "Lloyd Thyro-Tab 0.200 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "5,771,989 tablets", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: HD29411, Exp May-13; HE00512, Exp Jul-13; HF062122, Exp Sep-13."}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "135 vials", "code_info": "Lot #: a) Hydroxocobalamin 1000 mcg/mL 30 mL: 20130321-C, Exp 6/21/2013; 20130404-H, Exp 7/3/2013; 20130225-H, Exp 5/25/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Hydroxocobalamin Injection, all strengths and all presentations including a) Hydroxocobalamin 1000 mcg/mL 30mL and b) Hydroxocobalamin 1000 mcg/mL 10 mL P.F., Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-374-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-480-2013", "product_description": "Hydroxycobalamin Inj 1000mcg/ml MDV: 10 ml, 15 ml, 20 ml, 30 ml  Subcutaneous, 90 day expiration,", "product_quantity": "7", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-472-2013", "product_description": "Chlorhexidine Opth Soln 0.02%, 10 ml  Opthalmic Soln, 30 day expiration,", "product_quantity": "1", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"country": "United States", "city": "Foster City", "address_1": "333 Lakeside Drive", "reason_for_recall": "Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).", "address_2": "", "product_quantity": "3,181 vials", "code_info": "Lot #: B120217A, Exp 05/15 - US Distribution", "center_classification_date": "20130516", "distribution_pattern": "Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.", "state": "CA", "product_description": "Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA  94404, UPC 3 61958 01011 5; NDC 61958-0101-1.", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "Gilead Sciences, Inc.", "recall_number": "D-324-2013", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "64267", "termination_date": "20140106", "more_code_info": "", "recall_initiation_date": "20130131", "postal_code": "94404-1147", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-477-2013", "product_description": "HCG Inj 1200un/ml MDV, 10 ml  Subcutaneous, 30 day expiration,", "product_quantity": "3", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077627"], "brand_name": ["TOPIRAMATE"], "generic_name": ["TOPIRAMATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-108", "68462-153", "68462-109", "68462-110"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOPIRAMATE"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_id": ["e06f7da2-08df-4336-82c1-fe637019c819"], "spl_set_id": ["35312f49-decf-428d-bf5f-4215b762ed3c"], "package_ndc": ["68462-108-60", "68462-108-05", "68462-108-10", "68462-153-60", "68462-153-05", "68462-153-10", "68462-109-60", "68462-109-05", "68462-109-10", "68462-110-60", "68462-110-05", "68462-110-10"], "is_original_packager": [true], "upc": ["0368462109601", "0368462153604", "0368462110607", "0368462108604"], "nui": ["N0000008486", "N0000185506", "N0000182140"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["0H73WJJ391"]}, "product_type": "Drugs", "event_id": "64995", "recalling_firm": "Glenmark Generics Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-331-2013", "product_description": "Glenmark Topiramate Tablets, 200 mg,  60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India Manufactured for :  Glenmark Generics USA Mahwah, NJ 07430", "product_quantity": "9624 bottles", "reason_for_recall": "Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.", "recall_initiation_date": "20130405", "center_classification_date": "20130516", "termination_date": "20141009", "report_date": "20130522", "code_info": "Lot# 02123782, Exp 11/14", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "64710", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-312-2013", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 10 mg over 9 hours (1.1 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5552-3.", "product_quantity": "335,910 patches", "reason_for_recall": "Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.", "recall_initiation_date": "20130131", "center_classification_date": "20130502", "termination_date": "20161228", "report_date": "20130508", "code_info": "Lot #59824, Exp 04/13", "more_code_info": ""}, {"country": "United States", "city": "El Paso", "address_1": "1550 Northwestern Drive", "reason_for_recall": "Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.", "address_2": "", "product_quantity": "3,032,000 applicators", "code_info": "a) All lots with expiry between 02/12 to 10/15; b) All lots with expiry between 09/11 to 12/13; and c) All lots with expiry between 12/11 to 12/11.", "center_classification_date": "20130328", "distribution_pattern": "Nationwide, Puerto Rico, Virgin Islands, Malaysia, and United Kingdom", "state": "TX", "product_description": "SEPP 2% Iodine Tincture USP (47% v/v Ethyl Alcohol, 2% w/v Iodine, USP, Sodium Iodide USP, & Purified Water USP), packaged in a) 200-count applicators (Net 0.67 mL each) per carton, Cat. No 260261, NDC 54365-161-01, CareFusion, Leawood, KS 66211; b) 3000-count applicators (Net 0.67 mL each) per case, Cat. No 260431, NDC 54365-151-01, CareFusion, Leawood, KS 66211; and c) 3000-count applicators (Net 0.67 mL each) per case, Reorder TA6200, Manufactured for: Tri-State Hospital Supply Corporation, Howell, MI  48843.", "report_date": "20130403", "classification": "Class II", "openfda": {}, "recalling_firm": "CareFusion 213, LLC", "recall_number": "D-225-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64583", "termination_date": "20140512", "more_code_info": "", "recall_initiation_date": "20130304", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021840"], "brand_name": ["CAMRESE"], "generic_name": ["LEVONORGESTREL / ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3134"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238019", "248310", "749761", "1149667"], "spl_id": ["04a4ff1e-d39b-4ae3-8d13-fe07bc2f582a"], "spl_set_id": ["0e198d28-4986-4b93-833f-17c7ed4ce13e"], "package_ndc": ["0093-3134-91", "0093-3134-82", "0555-3134-82"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "64608", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-497-2013", "product_description": "Camrese(TM) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg and Ethinyl Estradiol 0.01 Tablets, 2 Extended-Cycle Tablet Dispensers (NDC 0093-3134-82) and 1 Extended-Cycle Tablet Dispenser NDC 0093-3134-91), 91 Tablets Each, Rx only, TEVA Womens Health Inc., Subsidiary of TEVA Pharmaceuticals, Inc., Sellersville, PA", "product_quantity": "120,049 blister packs", "reason_for_recall": "Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing", "recall_initiation_date": "20130314", "center_classification_date": "20130530", "termination_date": "20140115", "report_date": "20130605", "code_info": "NDC 0555-3134-82 and 0093-3134-91 -- lot numbers 33802566A, exp 3/2013; 33802967A, exp 8/2013; 33803529A, exp 10/2013; and 33803609A, exp 11/2013."}, {"status": "Terminated", "city": "Peapack", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA018655"], "brand_name": ["NORPACE CR"], "generic_name": ["DISOPYRAMIDE PHOSPHATE"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0025-2732", "0025-2752", "0025-2762", "0025-2742"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DISOPYRAMIDE PHOSPHATE"], "rxcui": ["209066", "209692", "309958", "309960", "636793", "636794", "902648", "902652"], "spl_id": ["4c146f11-42eb-4767-85e7-edb4b1f0b2cc"], "spl_set_id": ["e2aa1642-d262-4520-bc6a-9fd3ad795677"], "package_ndc": ["0025-2752-31", "0025-2762-31", "0025-2732-31", "0025-2742-31", "0025-2742-51"], "is_original_packager": [true], "upc": ["0300252752314", "0300252762313", "0300252742315", "0300252732316"], "unii": ["N6BOM1935W"]}, "product_type": "Drugs", "event_id": "65324", "recalling_firm": "Pfizer Inc", "address_1": "100 North Route 206", "address_2": "", "postal_code": "07977", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-607-2013", "product_description": "Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.", "product_quantity": "5,410 botlles", "reason_for_recall": "Failed Dissolution Specification", "recall_initiation_date": "20130531", "center_classification_date": "20130619", "termination_date": "20150605", "report_date": "20130626", "code_info": "Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13", "more_code_info": ""}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "109 vials", "code_info": "Lot #: Polidocanol 5% 30 mL: 20130319-I, Exp 6/19/2013; 20130326-H, Exp 6/26/2013; b) Polidocanol 1% 30 mL: 20130118-B, Exp 4/18/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Polidocanol Injection, all strengths and all presentations including a) Polidocanol 5% 30 mL, b) Polidocanol 1% 30 mL, c) Polidocanol 2% 30 mL, d) Polidocanol 3% 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-400-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-520-2013", "product_description": "Cardec Drops,Antihistamine, Nasal Decongestant, 1 fl oz. bottle, OTC, Manufactured for: Macoven Pharmaceuticals, Magnolia, TX 77354 NDC 44183-604-30", "product_quantity": "26,536 bottles - 30 mL", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11DQ009 Exp. 03/13; Lot# 11JQ002 Exp. 08/13."}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "13 vials", "code_info": "Lot #: a) Progesterone 100 mg/mL 10 mL: 20130306-E, Exp 6/6/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Progesterone Injection, all strengths and all presentations including a) Progesterone 100 mg/mL 10 mL, 30 mL b) Progesterone 50 mg/mL 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-402-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64879", "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "address_1": "1850 Whitney Mesa Dr", "address_2": "Suite 180", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-407-2013", "product_description": "Sodium Bicarbonate Injection, all strengths and all presentations including: a) Sodium Bicarb 4.2% 5 mL PF, b) Sodium Bicarb 8.4% 50 mL SDV, c) Sodium Bicarbonate 8.4%, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "product_quantity": "6213 vials", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "recall_initiation_date": "20130410", "center_classification_date": "20130516", "termination_date": "20140321", "report_date": "20130522", "code_info": "Lot #: Sodium Bicarb 4.2% 5 mL PF: 130123150AE, Exp 4/23/2013; b) Sodium Bicarb 8.4% 50 mL SDV: 20130315-L, Exp 6/15/2013; c) Sodium Bicarbonate 8.4%: 20130117-D, Exp 4/17/2013; 20130117-E, Exp 4/17/2013; 20130117-F, Exp 4/17/2013; 20130121-B, Exp 4/21/2013; 20130121-C, Exp 4/21/2013; 20130121-D, Exp 4/21/2013; 20130121-E, Exp 4/21/2013; 20130121-F, Exp 4/21/2013; 20130121-H, Exp 4/21/2013; 20130121-I, Exp 4/21/2013; 20130121-J, Exp 4/21/2013; 20130121-K, Exp  4/21/2013; 20130124-D, Exp 4/24/2013; 20130124-E, Exp 4/24/2013; 20130129-B, Exp 4/29/2013; 20130129-C, Exp 4/29/2013; 20130129-D, Exp 4/29/2013; 20130129-K, Exp 4/29/2013; 20130129-L, Exp 4/29/2013; 20130129-M, Exp  4/29/2013; 20130131-I, Exp 4/30/2013; 20130131-J, Exp  4/30/2013; 20130131-K, Exp 4/30/2013; 20130201-B, Exp 5/1/2013; 20130201-C, Exp  5/1/2013; 20130211-A, Exp  5/11/2013; 20130211-B, Exp  5/11/2013; 20130211-C, Exp 5/11/2013; 20130211-D, Exp 5/11/2013; 20130211-E, Exp  5/11/2013; 20130211-F, Exp 5/11/2013; 20130211-G, Exp  5/11/2013; 20130211-H, Exp 5/11/2013; 20130211-I, Exp 5/11/2013; 20130211-J, Exp 5/11/2013; 20130211-K, Exp 5/11/2013; 20130211-L, Exp 5/11/2013; 20130211-N, Exp 5/11/2013; 20130211-O, Exp 5/11/2013; 20130211-P, Exp 5/11/2013; 20130211-Q, Exp 5/11/2013; 20130211-R, Exp 5/11/2013; 20130211-S, Exp 5/11/2013; 20130211-T, Exp 5/11/2013; 20130214-D, Exp 5/14/2013; 20130214-E, Exp 5/14/2013; 20130214-H, Exp 5/14/2013; 20130215-A, Exp 5/15/2013; 20130215-B, Exp 5/15/2013; 20130215-D, Exp 5/15/2013; 20130215-E, Exp 5/15/2013; 20130215-G, Exp 5/15/2013; 20130215-H, Exp 5/15/2013; 13021840GV3, Exp 5/18/2013; 20130219-G, Exp 5/19/2013; 20130219-H, Exp 5/19/2013; 20130219-I, Exp 5/19/2013; 20130219-J, Exp 5/19/2013; 20130221-B, Exp 5/21/2013; 20130221-A, Exp 5/21/2013; 20130221-E, Exp 5/21/2013; 20130221-F, Exp 5/21/2013; 20130221-G, Exp 5/21/2013; 20130221-H, Exp 5/21/2013; 20130221-P, Exp 5/21/2013; 20130221-Q, Exp 5/21/2013; 20130221-S, Exp 5/21/2013; 20130222-B, Exp 5/22/2013; 20130222-C, Exp 5/22/2013; 20130225-E, Exp 5/25/2013; 20130225-F, Exp 5/25/2013; 20130225-G, Exp 5/25/2013; 201302256-GV4, Exp 5/25/2013; 20130227-P, Exp 5/27/2013; 20130227-Q, Exp 5/27/2013; 20130227-R, Exp 5/27/2013; 20130227-S, Exp 5/27/2013; 20130227-T, Exp 5/27/2013; 20130228-F, Exp 5/28/2013; 20130228-G, Exp 5/28/2013; 20130204-I, Exp 5/4/2013; 20130205-D, Exp 5/5/2013; 20130205-E, Exp 5/5/2013; 20130205-F, Exp 5/5/2013; 20130206-E, Exp 5/6/2013; 20130206-F, Exp 5/6/2013; 20130206-I, Exp 5/6/2013; 20130206-J, Exp 5/6/2013; 20130206-K, Exp 5/6/2013; 20130206-L, Exp 5/6/2013; 20130207-C, Exp 5/7/2013; 20130207-D, Exp 5/7/2013; 20130207-E, Exp 5/7/2013; 20130301-B, Exp 6/1/2013; 20130312-A, Exp 6/12/2013; 20130312-B, Exp 6/12/2013; 20130312-C, Exp 6/12/2013; 20130312-D, Exp 6/12/2013; 13031240GV4, Exp 6/12/2013; 20130313-J, Exp 6/13/2013; 20130313-K, Exp 6/13/2013; 20130314-G, Exp 6/14/2013; 20130314-L, Exp 6/14/2013; 20130314-M, Exp 6/14/2013; 20130315-L, Exp 6/15/2013; 20130315-M, Exp 6/15/2013; 20130315-N, Exp 6/15/2013; 20130318-H, Exp 6/18/2013; 20130319-D, Exp 6/19/2013; 20130319-K, Exp 6/19/2013; 20130319-L, Exp 6/19/2013; 20130320-G, Exp 6/20/2013; 20130320-H, Exp 6/20/2013; 20130320-I, Exp 6/20/2013; 20130320-J, Exp 6/20/2013; 20130320-K, Exp 6/20/2013; 20130320-L, Exp 6/20/2013; 20130325-I, Exp 6/25/2013; 20130325-J, Exp 6/25/2013; 20130325-L, Exp 6/25/2013; 20130325-M, Exp 6/25/2013; 20130325-N, Exp 6/25/2013; 20130327-D, Exp 6/27/2013; 20130327-E, Exp 6/27/2013; 20130327-F, Exp 6/27/2013; 20130327-G, Exp 6/27/2013; 20130327-H, Exp 6/27/2013; 20130327-I, Exp 6/27/2013; 20130327-J, Exp 6/27/2013; 20130327-K, Exp 6/27/2013; 20130327-L, Exp 6/27/2013; 20130327-M, Exp 6/27/2013; 20130327-N, Exp 6/27/2013; 20130329-D, Exp 6/29/2013; 20130329-E, Exp 6/29/2013; 20130329-F, Exp 6/29/2013; 20130329-G, Exp 6/29/2013; 20130304-B, Exp 6/4/2013; 20130304-C, Exp 6/4/2013; 20130304-D, Exp 6/4/2013; 20130304-E, Exp 6/4/2013; 20130304-F, Exp 6/4/2013; 20130304-G, Exp 6/4/2013; 20130304-H, Exp 6/4/2013; 20130304-I, Exp 6/4/2013; 20130306-A, Exp 6/6/2013; 20130306-B, Exp 6/6/2013; 20130306-C, Exp 6/6/2013; 20130306-D, Exp 6/6/2013; 20130306-I, Exp 6/6/2013; 20130306-J, Exp 6/6/2013; 20130306-K, Exp 6/6/2013; 20130308-A, Exp 6/8/2013; 20130308-B, Exp 6/8/2013; 20130308-C, Exp 6/8/2013; 20130308-D, Exp 6/8/2013; 20130308-E, Exp 6/8/2013; 20130308-F, Exp 6/8/2013; 20130401-D, Exp 7/1/2013; 20130401-E, Exp 7/1/2013; 20130401-F, Exp 7/1/2013; 20130404-B, Exp 7/4/2013; 20130404-C, Exp 7/4/2013", "more_code_info": ""}, {"country": "United States", "city": "El Paso", "address_1": "1550 Northwestern Drive", "reason_for_recall": "Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.", "address_2": "", "product_quantity": "929,000 kits", "code_info": "All lots with expiry between 12/11 to 10/15.", "center_classification_date": "20130328", "distribution_pattern": "Nationwide, Puerto Rico, Virgin Islands, Malaysia, and United Kingdom", "state": "TX", "product_description": "Blood Culture Prep Kit II containing 1 FREPP (70% isopropyl alcohol), Net 1.1 mL and 1 SEPP (iodine tincture 2% USP), Net 0.67 mL per kit, packaged in 20-count kits per carton, Cat. No 260307, NDC 54365-200-99, CareFusion, Leawood, KS  66211.", "report_date": "20130403", "classification": "Class II", "openfda": {}, "recalling_firm": "CareFusion 213, LLC", "recall_number": "D-227-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64583", "termination_date": "20140512", "more_code_info": "", "recall_initiation_date": "20130304", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-572-2013", "product_description": "Tri-Mix Injections in 5 mL and 10 mL vials (Alprostadil, Phentolamine and Papaverine), compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "4 vials of 5mL and 22 vials of 10mL", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65298", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the United States to FL, IL, MA, MO, MS, OH and TX.  No government or foreign distribution.", "recall_number": "D-606-2013", "product_description": "Actiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister (NDC 63459-502-01), b) 30 count carton (NDC 63459-502-30), Rx only, Manufactured by: Cephalon, Inc., Salt Lake City, UT 84116", "product_quantity": "316 cartons", "reason_for_recall": "Failed Dissolution Specification; during stability testing", "recall_initiation_date": "20130528", "center_classification_date": "20130619", "termination_date": "20140723", "report_date": "20130626", "code_info": "Lot C88583, exp. 06/15", "more_code_info": ""}]